Evidence map›Paper›PMID 35426523›Full record

ReviewWorld journal of microbiology & biotechnology2022

Recent advances in the microbial production of squalene.

Kalaivani Paramasivan, Sarma Mutturi

Open access · bronzeAbstract readReview
In one paragraph

Review in World journal of microbiology & biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Article
  3. De novo biosynthesis of Asperosaponin VI inSynthetic and systems biotechnology · 2025
    Article
  4. ACS omega · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Optimization of Squalene Production byMolecules (Basel, Switzerland) · 2025
    Article
  11. Overexpression of tRNA mFrontiers in microbiology · 2025
    Article
  12. Review
  13. Review
  14. Article
  15. Efforts toward Ambergris Biosynthesis.Chem & bio engineering · 2024
    Review
  16. Natural Products Biosynthesis byAntibiotics (Basel, Switzerland) · 2024
    Article
  17. Engineering peroxisomal biosynthetic pathways for maximization of triterpene production inProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  18. Anti-Infection of Oral Microorganisms from Herbal Medicine ofDrug design, development and therapy · 2024
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Kalaivani ParamasivanMicrobiology and Fermentation Technology Department, CSIR-Central Food Technological Research Institute, Mysore, India.
Sarma MutturiMicrobiology and Fermentation Technology Department, CSIR-Central Food Technological Research Institute, Mysore, India. smutturi@cftri.res.in.ORCID http://orcid.org/0000-0002-3251-8643
Central Food Technological Research Institute · IN

Funding

Science and Engineering Research Board CRG/2019/003323
6 · The paper itself

Abstract

Squalene is a triterpene hydrocarbon, a biochemical precursor for all steroids in plants and animals. It is a principal component of human surface lipids, in particular of sebum. Squalene has several applications in the food, pharmaceutical, and medical sectors. It is essentially used as a dietary supplement, vaccine adjuvant, moisturizer, cardio-protective agent, anti-tumor agent and natural antioxidant. With the increased demand for squalene along with regulations on shark-derived squalene, there is a need to find alternatives for squalene production which are low-cost as well as sustainable. Microbial platforms are being considered as a potential option to meet such challenges. Considerable progress has been made using both wild-type and engineered microbial strains for improved productivity and yields of squalene. Native strains for squalene production are usually limited by low growth rates and lesser titers. Metabolic engineering, which is a rational strain engineering tool, has enabled the development of microbial strains such as Saccharomyces cerevisiae and Yarrowia lipolytica, to overproduce the squalene in high titers. This review focuses on key strain engineering strategies involving both in-silico and in-vitro techniques. Emphasis is made on gene manipulations for improved precursor pool, enzyme modifications, cofactor regeneration, up-regulation of limiting reactions, and downregulation of competing reactions during squalene production. Process strategies and challenges related to both upstream and downstream during mass cultivation are detailed.

Indexed as

SqualeneYarrowiaAnimalsMetabolic EngineeringSaccharomyces cerevisiaeSqualeneS. cerevisiaeSqualeneStrain engineeringTerpene

Identifiers

PMID35426523
PMCPMC9010451
OpenAlexW4223981336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.